Midodrine Teva (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Teva, is a Alpha-1 adrenergic agonist presented as an oral tablet for oral use. It is used to treat orthostatic hypotension in adults by raising blood pressure when standing. The medication is formulated for systemic absorption and is prescribed when conventional measures such as fluid intake and compression stockings are insufficient.

GNH USA supplies Midodrine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics to support the needs of healthcare providers across multiple regions.

Midodrine acts on the vascular system to counteract low blood pressure associated with orthostatic disorders.

- Orthostatic hypotension: increases standing blood pressure and reduces dizziness and fainting episodes. - Neurogenic orthostatic hypotension: improves autonomic regulation of vascular tone in patients with autonomic failure. - Post‑ural hypotension: helps maintain adequate cerebral perfusion after prolonged standing.

Midodrine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Piloerection (goosebumps) - Pruritus (itching) - Urinary retention - Supine hypertension - Headache

Serious or Rare Side Effects: - Severe hypertension leading to chest pain or stroke - Bradycardia or cardiac arrhythmias - Anaphylactic or severe allergic reactions

Before prescribing Midodrine, clinicians should consider several precautionary measures to ensure patient safety.

- Blood pressure monitoring: check supine and standing measurements before and during therapy. - Cardiovascular disease: avoid in patients with severe ischemic heart disease or uncontrolled hypertension. - Renal impairment: use caution and consider dose adjustment in severe renal dysfunction. - Pregnancy and lactation: safety has not been established; prescribe only if potential benefit outweighs risk. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Midodrine may interact with other medicines, requiring careful assessment before co‑administration.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): additive hypertensive effect. - Other α1‑adrenergic agonists (e.g., phenylephrine): risk of excessive vasoconstriction. - Direct vasopressors (e.g., norepinephrine): may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate orthostatic hypotension when therapy is withdrawn. - Antihypertensive agents (ACE inhibitors, beta‑blockers): monitor for excessive blood pressure lowering. - Tricyclic antidepressants: possible increase in blood pressure. - SSRIs or SNRIs: may modestly affect blood pressure response.